KR101513247B1 - A composition comprising extracts of herbal mixture for treating or preventing respiratory disease - Google Patents

Abstract

The present invention relates to a composition containing an extract of a herbal medicine mixture, which comprises an extract of a herbal medicine mixture, which comprises an extract of a herbal medicine mixture, It is excellent in the therapeutic effect of asthma through it and can be easily used as a pharmaceutical composition or health functional food for prevention, treatment or improvement of respiratory diseases.

Description

[0001] The present invention relates to a composition for preventing or treating a respiratory disease,

The present invention relates to a composition for the prevention or treatment of respiratory diseases containing an extract of a crude drug mixture, and more particularly to a composition for preventing or treating respiratory diseases containing an extract of a crude drug mixture ≪ / RTI >

Asthma, chronic obstructive pulmonary disease, allergic rhinitis, cough, sputum, acute chronic bronchitis, bronchiolitis, sore throat, tonsillitis, and laryngitis are typical diseases of respiratory diseases.

Asthma refers to chronic inflammation of the airways, especially the bronchi. Inflammation caused by asthma can be exacerbated by a wide variety of scrapes, including smoke, allergic antigens, cold winds, exercise, and respiratory infections, and persistent inflammation causes airway deformation and hyper-responsiveness. These causes include general symptoms such as wheezing (wheezing, narrowing of the airways, wheezing or cramps), breathing, coughing, and excessive sputum production.

Asthma can be summarized by four pathological symptoms: the inflow of eosinophils in the airways is markedly increased, mucus is excessively secreted, edema is observed, and airway ) Is narrowed.

The respiratory tract is composed of the muscles of the mucous membrane and the bronchial smooth muscle, and there are many secretory glands in the mucous membrane, which keeps secretion of necessary secretions. When the bronchial smooth muscle contracts, the respiratory rate becomes narrower. When inflammation occurs due to a wide variety of scabies such as soot, cold allergy, exercise, and respiratory infections, the secretions from the secretory glands are further increased and this secretion blocks the airway and causes the mucosa to swell inward to narrow the airway . As a result, seizure coughing and dyspnea accompanied by lethargy are severe, and when seizure occurs, dry coughing occurs and chest tightness is felt. There are many asthmatics with symptoms of respiratory distress that can not be diagnosed with chronic coughing and chest tightness without any symptoms. These symptoms tend to appear suddenly in their everyday lives.

At present, asthma is a chronic bronchitic inflammatory disease in bronchial stenosis, and it is important to alleviate it when symptoms are present, but it is important to treat inflammation in a long term.

Asthma is a disease or condition that causes airway inflammation, airway-hyperresponsiveness (AHR), mucin hypersecretion, and immunologically, infiltration of eosinophils , An increase in the number of Th2 cells and an increase in the number of activated mast cells compared with the number of Th1 cells. As a symptom of asthma, eosinophil infiltration of the granulocyte lineage of white blood cells is typical characteristic of eosinophils, and eosinophils play a very important role in asthma's condition / physiology by producing various inducers that promote airway inflammation and bronchoconstriction . The asthma-inducing antigens induce the differentiation of T cells into Th2 cells, and Th2 cells produce IL-5, granulocyte-macrophage stimulating factor (GM-CSF), IL-3, IL-13 and IL-4 Secrete cytokines, and IL-4 acts on B cells to stimulate the production of IgE and activate mast cells. Activation of inflammatory cells, such as mast cells, is advantageous for various inflammatory mediators and causes acute inflammatory responses such as bronchoconstriction, vasodilation, sensory neuropathy, and cholinergic bronchoconstriction in the airways. Most asthma is reversible, but in some patients remodeling occurs due to changes in the airway structure due to fibrosis, elevation of vascular and mucus secretory cells and thickening of the airway smooth muscle as the asthma progresses, and chronic obstructive pulmonary disease (COPD) may also occur in patients with chronic obstructive pulmonary disease (COPD).

Chronic obstructive pulmonary disease (COPD) refers to a group of diseases in which the air velocity decreases due to airway obstruction without causing lung or heart disease. Chronic obstructive pulmonary disease (COPD) is defined as chronic bronchitis with chronic sputum accompanied by sputum, and abnormal pulmonary vesicles with end-bronchial organs that are abnormally enlarged and pulmonary alveoli destroyed. Chronic obstructive pulmonary disease, like asthma, manifests as airway disease symptoms such as dyspnea, cough, and sputum, which then exacerbate lung function and eventually lead to death. The major cause of the disease is smoking, and it is known to be caused by pollutants, congenital diseases, respiratory infections, and by neutrophils and macrophages. This is a major inflammatory cell that secretes many kinds of proteolytic enzymes, resulting in destruction of lung parenchyma and chronic mucus secretion. Macrophages have recently become important inflammatory cells of IFN-γ (interferon-γ) and IL-13 overexpression (TGF-β [transforming growth factor-β]], which is involved in wound healing, as well as secretes mediators (ROS [reactive oxygen species], nitric oxide metabolites, FGF2 [fibroblast growth factor 2], VEGF [endothelial growth factor], and the like. The irreversible airway obstruction is characterized by emphysema of the airway obstruction due to destruction of the alveoli, small airway fibrosis (obstructive bronchiolitis) characterized by fibrosis due to inflammation of the bronchus bronchus and subsequent repetitive damage. . Most patients with these diseases are accompanied by inflammation and fibrosis of the lower airways with emphysema.

Both asthma and chronic obstructive pulmonary disease are symptoms of airway diseases such as dyspnea, cough, and sputum, and there is no common cause for the disease itself. Currently, there are only two treatments for asthma: a controller that suppresses inflammation and a reliever that relieves dyspnea. This is because asthma is caused by a wide variety of oncogenic factors and inducers, compared with the appearance of the symptoms. It is thought that it is difficult to study the disease itself. In particular, most of the severe persistent asthma-related mortality and economic burden, which are a significant part of the economic burden, have been treated with high-dose steroids, but asthma is still not well controlled. Asthma treatment should be accompanied by medication, environmental therapy (avoiding therapy) and immunotherapy. If left for a long time, scarring occurs in the mucous membrane of the bronchial tube, which can not be recovered. It is important to treat the bronchial mucosa, and even if the symptoms disappear, the inflammation of the bronchial mucosa continues, leading to bronchial damage. Therefore, thorough treatment is necessary. Asthma is chronic and temporarily reversible and may recur, and even worse during treatment, especially in pediatric asthma, it is often easier to cure by reducing the number of asthma attacks and reducing the severity of seizures. Because asthma is an allergic disease, it is not easy to treat it. If it is not a fundamental treatment, it will recur easily when exposed to a triggering environment.

Another common respiratory disease, allergic rhinitis, is also known as nasal allergies or allergic rhinitis. Sudden onset, sneezing suddenly, a lot of clear nasal discharge, nasal obstruction, and head heavy and tear Also. It is called vasomotor rhinitis, a condition in which the symptoms are very similar and the antigen is not clear. In other words, when you get up in the morning of the day and your body temporarily cools down, the symptoms mentioned above may be recovered within a few hours, and many occur during the turn of the year or during the cold season. It is often confused with a cold, which is different from a cold, often accompanied by asthma or urticaria.

Allergic reactions of allergic rhinitis are caused by a type of antigen and antibody hypersensitivity, histamine in the cell membrane of mast cells and basophils is liberated, arachidonic acid is released, cyclooxygenase (COX) and 5-lipoxygenase (5-lipoxygenase, 5-LO) to mediate prostaglandins and rucotrienes, which show an initial response between 2 and 90 minutes of antigen exposure and a late response after 4 to 8 hours. The initial response is mainly mediated by the mediator, and the late response is mainly by cellular infiltration. In addition, both allergic and nonallergic rhinitis act as risk factors for the development of asthma. Treatment of allergic rhinitis is performed when desensitization is performed when the antigen is evident, and other drug therapy, surgical therapy, and physical therapy, but it is difficult to be completely cured.

Pyothorax is a phenomenon of pus in the pleural cavity, which is the space between the pleura surrounding the thorax and the lung. The most common cause is staphylococcal pneumonia, followed by pneumococci, influenza, and the like. Bacteria entering the lungs spread to the surrounding pleural cavity.

Cough, sputum is caused by cold air, external foreign substances including pathogenic microorganisms, physicochemical factors such as air pollutants and allergens. Coughing is a defense mechanism that occurs reflexively by airway mucosal stimulation. If persistent coughing is induced by excessive stimuli, the quality of life of the patient is reduced and worsened. In addition, when dust or irritant substances are introduced from the outside by the same principle as coughing, the bronchus of our body pushes out with the saliva along with the saliva, which causes the formation of sputum (sputum) There will be a dense purulent sputum. At this time, the cure-suppressing treatment is called Jinseong (鎭 咳), and the treatment for suppressing the sputum is called gutum (祛痰).

Acute bronchitis is not an independent disease but is accompanied by other illnesses. Acute bronchitis often accompanies upper respiratory infections such as nasopharyngitis and influenza, pertussis, measles, typhoid, diphtheria, and scarlet fever, all of which are caused by viral infection except bacterial diseases. Staphylococcus aureus, Staphylococcus aureus, Hemophilus influenza, and several types of laboratory bacterium are found in sputum, but this does not mean that it is caused by bacterial infection, and antibiotic treatment does not affect the course of the disease. Main symptoms include redness, swelling, and dryness of the bronchial mucosa, and mucus or purulent secretions from the bronchi. It usually resolves without causing any complications, but chronic progression can lead to swelling, thickening, and atrophy of the mucous membranes. Prolonged fibrosis, bronchopulmonary stenosis, or emphysema may occur in the long term .

Chronic bronchitis is a disease that lasts for 2 consecutive years, has sputum more than 3 months in a year, and persists coughing. It is estimated that smoking, air pollution, occupational exposure, and other stimuli cause bronchial injury, resulting in chronic bronchitis. Chronic cough, sputum and dyspnea are the main symptoms. When the disease progresses, the respiratory difficulty gradually increases over a period of several months to several years, so that even a little activity causes difficulty in breathing.

Laryngitis is caused by inflammation of the larynx itself caused by infection with viruses or bacteria, or by inflammation of surrounding tissues such as pharyngitis and tonsillitis, which are spread to the larynx. It is often a partial symptom of cold. Most of them are accompanied by nose cold (acute rhinitis) or pharyngitis, coughing occurs and voices change. Laryngitis is an infectious disease commonly referred to as respiratory disease, and it is difficult to clearly distinguish it from pharyngitis, laryngitis, and bronchitis.

Bronchiolitis (bronchiolitis) is a disease that causes irritation of the lining of the lungs, causing bronchiolitis. The inflammation of the inner lining of the bronchial tube causes the inner wall cells to clump or swell, narrowing the lumen and causing dyspnea, which is contagious and often prevalent. Bronze bronchus carries air from the bronchi to the alveoli and alveoli supply oxygen to the blood. Causes can be infected with viruses or bacteria, or both. In some cases, the illness may occur every time a person catches a cold. Risk factors include respiratory infections, family history of allergic diseases, and obesity, among other diseases that reduce resistance. Complications include persistent pulmonary disease, chronic bronchitis, partial collapse of the lungs, bronchiectasis, recurrence of pneumonia, and rarely cause chronic obstructive pulmonary disease.

Laryngopharyngitis is a common cold, throat and upper respiratory infection. Beta hemolytic streptococcus, staphylococcus aureus, pneumococcus, bacteria such as hemophilus and anaerobic strain, or viruses such as influenza virus, herpes simplex virus, parainfluenza virus, coxsack virus, It is acute and chronic. It is acute and chronic. Acute is caused by sudden temperature changes, cold, febrile disease, overwork, weak constitution, bacterial infection, chronic, acute sore throat repeatedly recurrence or excessive smoking, drinking, overwork, irritating food intake, Laryngopharyngeal reflux disease and other causes. In rare cases, irritating gases, chemicals, chemical vapors, or inflammation may spread from adjacent areas, such as the sinuses.

As described above, respiratory diseases such as asthma, chronic obstructive pulmonary disease, allergic rhinitis, cough, sputum, acute bronchitis, bronchiolitis, sore throat, tonsillitis and laryngitis have some differences in cause and symptom And the currently used medication, the airway dilator does not have the effect of inflammation which exacerbates the disease. Therefore, the symptom is only alleviated. Steroids, which are known to be effective in inflammation, are problematic for long-term use due to serious side effects. Therefore, the combination of the two is often prescribed in the form of an inhaler than the oral antibiotics due to the side effects of steroids are difficult to take the dose is poor compliance.

Therefore, there is a desperate need to overcome the limitations of such current drug therapies, to fundamentally treat the causes, and to develop new therapeutic agents that can effectively ameliorate the symptoms. However, since respiratory diseases are involved in various leukocyte cells and various cytokines and inflammatory mediators as described above, it is considered that it is difficult to effectively treat them as a single-component synthetic medicament, and herbal medicine extracts with various components and mechanisms It can be an effective treatment.

Macromuscular ( Liriope platyphylla ) uses root roots as herbs, which are used as anti-inflammatory, tonic, shinhae, expectorant and cardiovascular agents.

The underwear is made of Raphanus sativus L.) or the seeds of the same plants. This medicine is odorless, flavorless and sweet, and the properties are flat without any bias. The underwear has the effect of letting it pass through the stomach and lowering the stomach, so it is used only in the abdominal cavity, trimming, gastric hyperplasia, diarrhea. It is effective for sea water, asthma and constipation. It has the effect of treating anorexia and stopping old fences and old coughs. Pharmacological actions such as Staphylococcus aureus inhibition, skin fungus inhibition, hypotensive effect, and anti-inflammatory effects have been reported. It is also known as the nunnery by another name.

Lily (lily, lily) is a monocotyledonous lily lily and Lilium plant, and scales of lilies are used as herbal medicine. It is known to cure reproductive and abdominal pain, to cool the feces, to help the body, to stimulate energy, to treat the symptoms of the whole body, and to treat the symptoms of difficult breathing due to obstructed throat. It stops tears and runny nose. It is known that it is effective for sudden sickness, angina disease, fever and the like. It was used to improve mental and astonishing symptoms, dizziness after childbirth, eliminate the poison of poisonous pox, and treat the swelling of the flank, breast, and back.

Gakgyeong is a medicinal product made by removing roots or juniors of Platycodon grandiflorum A. De Candolle, which is a little bit odorous, has a very good taste, and has a fairly flat quality. Gyungyung works on the lungs to treat symptoms with a lot of seawater and sputum, uncomfortable breathing, clearing the lungs, releasing the stiff chest, releasing cold air in the stomach, stopping the cough and removing the wall. I do not see my urine, I have generalized edema, and even when the amount of urine is small. Sore throat, cold cough, sputum, nasal congestion, asthma, bronchial inflammation, pleurisy, headache, chills and tonsillitis. The pharmacological action was reported to be a gadam action, a hypoglycemic action, a cholesterol lowering action, and an inhibiting action of improving bacteria.

On the other hand, the inventors of the present invention have completed the present invention by confirming that the extract of the herbal medicine mixture including the mammon dong, the underwear, the lily, the gyungyang and the rice is excellent in the suppressive effect of respiratory diseases such as asthma and bronchitis.

(Korean Patent No. 974891 and Korean Patent No. 671432), which contains MacMundong and Gil-Kyung as a constituent, herbicidal compositions comprising Gakyung as a constituent (Korean Patent No. 527834 and Korean Patent No. 375560) have been shown to have therapeutic effects on respiratory diseases such as asthma and allergic rhinitis, but no prior art containing all the constituents of the crude drug mixture of the present invention has been found.

Korean Registered Patent No. 974891 (Method for preparing a composition for improving bronchial function mixed with herb medicine and herb extract and composition containing herbal medicine and herb extract prepared by this method, registered on August 3, 2010) Korean Registered Patent No. 671432 (Registered on Jan. 12, 2007 as a medicine for maintenance treatment of asthma) Korean Patent No. 527834 (registered as a pharmaceutical composition for the treatment of allergic diseases, November 3, 2005) Korean Registered Patent No. 375560 (Food Composition for Treatment of Bronchial Disease Containing Platycodon sp. Extract, registered on Feb. 26, 2003)

Nature, 1977, 270, 256 ~ 257. Kaminuma O et al., Inhibitory effect of a novel phosphodiesterase IV inhibitor, T-440, on antigen- and chemical mediator-induced bronchoconstrictions in guinea pigs in vivo., Jpn. J. Pharmacol., 1996, 72, 1-8. Kor. J. Pharmacogn., 1999, 30 [4], 377-383. Arakida Y et al., Effect of combined leukotriene D (4) and thromboxane (2) receptor antagonist on mediator-controlled resistance in guinea pigs, European Journal of Pharmacology, 2000, 403, 169-179. Anderson WH et al., An in vivo model for measuring antigen-induced SRS-A-mediated bronchoconstriction and plasma SRS-A levels in guinea-pig. J. Pharmac., 1983, 78, 67-74. Rogerio AP et al., Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice., Pharmacological Research, 2010, 61, 288-297. Won HY et al., Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation., Biochemical Pharmacology, 2010, 79, 888-986.

It is an object of the present invention to provide a composition for the prevention or treatment of respiratory diseases containing an extract of a crude drug mixture, and more particularly, to a respiratory medicine containing an extract of a crude drug mixture, And to provide a composition for preventing or treating diseases.

The present invention relates to a composition for the prevention or treatment of respiratory diseases, which comprises extracts of herbal medicine mixtures comprising ginseng root, underwear, lily, ginseng, and rice.

The herbal medicine mixture may contain 50-200 parts by weight of herbaceous fungus, 50-200 parts by weight of lily, 10-100 parts by weight of ginseng, and 10-50 parts by weight of rice, based on 100 parts by weight of ginseng root.

Wherein said herbal mixture contains 50 to 200 parts by weight of chicken hair, 10 to 100 parts by weight of oyster, 50 to 200 parts by weight of supernatant, 10 to 100 parts by weight of coriander, 10 to 100 parts by weight of corn husk, 10 to 100 parts by weight of corn husk, 100 to 100 parts by weight of ginger, 10 to 100 parts by weight of ginger, 10 to 100 parts by weight of jujube, and 10 to 100 parts by weight of licorice.

The extract of the crude drug mixture can be prepared by extracting a crude drug mixture containing marshmallow, lighter, lily, Gyeonggi, and rice with water, C1 to C4 lower alcohol or a mixed solvent thereof.

The present invention also provides a health functional food for preventing or ameliorating respiratory diseases, which comprises an extract of a herbal medicine mixture comprising the above-mentioned McDonald's, an underwear, a lily, a bean curd, and rice.

In a further aspect, the present invention provides a method for producing an extract of a herbal medicine mixture comprising ginseng root, underwear, lily, ginseng, and rice,

(1 step) preparing a herbal mixture by mixing 100 parts by weight of corn germ, 50-200 parts by weight of lingers, 50-200 parts by weight of lilies, 10-100 parts by weight of gill, and 10-50 parts by weight of rice.

(Step 2) Mixing the crude drug mixture of the above-mentioned one step with an extraction solvent having a total weight of 1 to 10 times the total weight of the crude drug mixture and extracting the mixture at 70 to 130 ° C for 1 to 10 hours; And

(Step 3) removing the solid content of the extract of the two steps and collecting the filtrate;

, It is possible to produce an extract of a herbal medicine mixture including a mungum-dong, an underwear, a lily, a ginseng, and rice.

Hereinafter, the present invention will be described in detail.

The rice used in the preparation of the extract of the herbal medicine mixture of the present invention can be used regardless of the variety or the state of the rice such as white rice, brown rice, glutinous rice, black rice and the like. At this time, rice is effective in suppressing sputum, cough, and the like by replenishing the essence of the lung.

The respiratory diseases may be all diseases causing inflammation and airway constriction. Generally, the respiratory diseases are asthma, chronic obstructive pulmonary disease, allergic rhinitis, bronchial adenoma, pulmonary tuberculosis, empyema, lung abscess, cough, sputum, bronchitis, Tonsillitis, and laryngitis.

The bronchial asthma may be selected from the group consisting of bronchial asthma, atopic asthma, atopic bronchial IgE mediated asthma, non-atopic asthma, allergic asthma and non-allergic asthma. The bronchial asthma may be selected from acute bronchitis, chronic bronchitis, bronchiolitis, Catarrhal bronchitis and obstructive and inflammatory bronchial diseases.

The extract of the crude drug mixture may be used in the form of a concentrate obtained by concentrating the extract at a reduced pressure or a dried product thereof when a C1 to C4 lower alcohol or a mixed solvent with water is used. In addition, in the case of extracting with water, the filtrate from which the solid content has been removed can be immediately used, and it can be used in the form of a concentrated product or a dried product thereof.

The chicken broth included in the herbal mixture may be chicken broth or frozen chicken broth of raw chicken, and chicken broth or frozen chicken broth of raw chicken may be used immediately. However, 100 to 500 parts by weight of chicken broth may be added to 100 to 500 parts by weight of boiled water, 20 to 20 parts by weight of ginger and 1 to 20 parts by weight of ginger are added to the chicken broth and boiled for 10 to 60 minutes. Other liquor may be used instead of the soju. When boiled chicken boiled with shochu and ginger, the fish 's fishy smell and grease are removed. The collagen ingredient contained in chicken legs has the effect of suppressing the dryness of the lung by supplementing the essence of the lung.

The extract of the crude drug mixture may be isolated by known methods used for separation and extraction of plant components, such as extraction with an organic solvent (alcohol, ether, acetone, etc.), partition with hexane and water, Or may be fractionated or purified by a suitable combination method.

The chromatography can be carried out using silica gel column chromatography, LH-20 column chromatography, ion exchange resin chromatography, medium pressure liquid chromatography chromatography, thin layer chromatography (TLC), silica gel vacuum liquid chromatography, and high performance liquid chromatography.

The present invention also provides a pharmaceutical composition for the prevention or treatment of respiratory diseases, which comprises extracts of herbal medicine mixtures comprising ginseng root, underwear, lilies, ginseng, and rice. The pharmaceutical compositions may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories and sterilized injection solutions according to conventional methods. Examples of carriers, excipients and diluents that can be contained in the pharmaceutical composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient, such as starch, calcium carbonate, sucrose, Or lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of the liquid preparation for oral use include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, simple diluents commonly used, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included . Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of the suppository base include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.

The dosage of the pharmaceutical composition of the present invention will depend on the age, sex, body weight of the subject to be treated, the particular disease or condition to be treated, the severity of the disease or condition, the route of administration and the judgment of the prescriber. Dosage determinations based on these factors are within the level of ordinary skill in the art and generally the dosage ranges from 0.01 mg / kg / day to approximately 2000 mg / kg / day, based on the composition comprising the concentrated dried product of the herbal mixture. A more preferable dosage is 1 mg / kg / day to 500 mg / kg / day. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.

The pharmaceutical composition of the present invention can be administered to mammals such as rats, livestock, humans, and the like in various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine dural or intracerebral injection. Since the compound of the present invention has little toxicity and side effects, it can be safely used even for long-term administration for preventive purposes.

In addition, the present invention provides a health functional food for preventing or improving respiratory diseases, which comprises an extract of a herbal medicine mixture and a food-acceptable food-aid additive, which includes marshmallow, underwear, lily, ginseng and rice. The health functional food of the present invention includes forms such as tablets, capsules, pills, and liquids. Examples of the foods to which the extract of the present invention can be added include various foods, beverages, gums, tea, vitamins , And health functional foods.

On the other hand, the composition for preventing or treating respiratory diseases containing extracts of the herbal medicine mixture containing the above-mentioned McDermidus, Lactuca, Liliaceae, Gyungyang, and rice is provided as a form easily sterilized and packaged in a pouch form It is possible.

The present invention relates to a composition containing an extract of a herbal medicine mixture, which comprises an extract of a herbal medicine mixture, which comprises an extract of a herbal medicine mixture, It is excellent in the therapeutic effect of asthma through it and can be easily used as a pharmaceutical composition or health functional food for prevention, treatment or improvement of respiratory diseases.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a flow chart showing a process for producing an extract of a crude drug mixture of the present invention. FIG.

Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein but may be embodied in other forms. Rather, the intention is to provide an exhaustive, complete, and complete disclosure of the principles of the invention to those skilled in the art.

EXAMPLES Example 1 Preparation of Extracts of Herbal Drugs Containing MacMyung Dong, Lingerie, Lily, Gyeongyang and Rice

The crude drug mixture of Table 1 below was mixed with 6 kg of water and extracted with a herbal extractor at 120 ° C for 9 hours. The solid content was removed to obtain an extract of each herbal mixture. At this time, the total weight of the crude drug mixture was 920 g. The rice used was white rice. In addition, chicken broth was made by defrosting frozen chicken broth, adding 100 g of soju and 200 g of ginger to 5 kg of boiling water per 2 kg of chicken broth, and then defrosting the defrosted chicken broth for 20 minutes (boiled water was discarded and chicken broth was rinsed twice in cold water Used for extraction of herbal medicine).

≪ Comparative Example 1 > Preparation of comparative herbal mixture extracts >

An extract of the crude drug mixture was prepared in the same manner as in Example 1 except that the mixing conditions of the herbal medicine were mixed under the conditions shown in Table 2 below.

< Experimental Example  1. Bronchial contraction inhibition test ( in vitro )>

1977, 270, 256 ~ 257; Jpn. J. Pharmacol., 1996, 72, pp. 1 ~ 8; Kor. J. Pharmacogn., 1999, 30 [4], 377-383).

For this purpose, a Hartley-type male guinea pig (400-500 g, BGI, Korea) was sensitized by intravenous injection of anti-ovalbumin anti-serum at a volume of 2 ml / kg. 48 hours after sensitization, the guinea pigs were sacrificed and the bronchi were removed. After this, other tissues attached to the bronchus were removed from the tyrode fluid, and then the incision was made in the shape of a ring including 2 to 3 cartilages. After the incision was made, the cartilage portion of the ring was cut while the bronchus muscle was preserved, the yarns were connected to both sides, and the suspension was suspended in an organ bath. After stabilization for a certain period of time, 10 g / ml of carbachol The maximum contraction was induced and the bronchus was washed and stabilized with tyrode solution. After 5 minutes, 5 μM of indomethacin was added and 1 minute of each extract (lyophilized and treated with 0.3 mg / ml) was added. After 5 minutes, 20 μg / ml of ovalbumin was added to induce contraction Respectively. The inhibition rate (%) of bronchial contraction was calculated by comparing the shrinkage by carbachol and ovalbumin, and the results are shown in Table 3. Bronchial contraction and relaxation were measured using a physiological activity meter (powerlab 8/30, ADInstument) connected to a force transducer (WPI).

Administration condition % Inhibition of bronchial contraction Example 1-1 60.3 Examples 1-2 77.5 Example 1-3 76.4 Examples 1-4 75.3 Examples 1-5 76.7 Examples 1-6 78.4 Examples 1-7 80.3 Examples 1-8 63.6 Examples 1-9 65.4 Comparative Example 1-1 33.5 Comparative Example 1-2 22.4 Comparative Example 1-3 25.7 Comparative Example 1-4 22.6 Comparative Example 1-5 14.5

As shown in Table 3, it was confirmed that the extract of the crude drug mixture of Example 1 had remarkably excellent bronchoconstriction suppressing activity as compared with the extract of Comparative Example 1. [

<Experimental Example 2> Airway contraction inhibition test ( in vivo )>

It was confirmed that the extract of the herbal medicine mixture prepared in Example 1 and Comparative Example 1 had an airway contraction inhibitory activity (Experimental method - confirmation of measurement of volume: European Journal of Pharmacology, 2000, 403, 169-179; Br. J. Pharmac , 1983, 78, 67-74).

For this purpose, Hartlyn-type male guinea pigs (400 to 450 g, SLC, Japan) were sensitized by intravenous injection of anti-albumin antiserum at a volume of 1.5 ml / kg. 48 hours after sensitization, the lyophilized product of each extract (400 mg / kg) was orally administered to guinea pigs. After 30 minutes of oral administration, pyrilamine maleate (0.5 mg / kg) and propranolol (0.05 mg / kg) were pre-treated by subcutaneous injection. To measure respiration indexes of guinea pigs, (RxV) was measured in a double chamber plethysmograph box equipped with a plethysmometer (plethysmograph box type 855, HSE, German). After 30 minutes of pretreatment, 1% egg albumin was aerosolized using high-pressure compressed air and sprayed for 2 minutes, and air containing albumin in the chamber was flown out for 30 seconds. Airway resistance was measured in a pellet-thymometric box for 15 minutes, airway resistance was calculated as area under the curve (AUC), and airway contraction inhibition rate (%) was shown in Table 4 as compared with the solvent control .

Administration condition Airway contraction inhibition (%) Example 1-1 50.4 Examples 1-2 55.5 Example 1-3 56.7 Examples 1-4 53.3 Examples 1-5 54.4 Examples 1-6 57.5 Examples 1-7 66.6 Examples 1-8 53.5 Examples 1-9 52.7 Comparative Example 1-1 24.6 Comparative Example 1-2 15.4 Comparative Example 1-3 16.5 Comparative Example 1-4 18.3 Comparative Example 1-5 13.8

As shown in Table 4, it was confirmed that the extract of crude drug mixture of Example 1 was significantly superior to the extract of Comparative Example 1 in the airway contraction inhibitory activity.

<Experimental Example 3> Test for suppressing bronchial inflammation>

In order to examine whether the extract of the herbal medicine mixture prepared in Example 1 and Comparative Example 1 had an inhibitory effect on pulmonary bronchial inflammation in asthma and chronic obstructive pulmonary disease models, (Pharmacological Research, 2010, 61, 288-297; Biochemical Pharmacology, 2010, 79, 888-896).

To this end, 0.2 ml of a 1: 1 mixed solution of 10 μg of ovalbumin (OVA, sigma) and 4 mg of aluminum hydroxide (Alum, Pierce) was added to BALB / c female mice (6.5 weeks old, SLC, Japan) 0.0 &gt; 0, &lt; / RTI &gt; 7, and 14 days. After 8 days and 10 days after the last sensitization, 1.0% egg albumin was aerosolized with high pressure compressed air and sprayed for 50 minutes to induce airway inflammation. Each test substance (lyophilisate of each extract, 400 mg / kg, bid) was challenged by oral administration twice a day from the 21st to 23rd day after the first sensitization. Twenty-four hours after the last challenge, bronchial alveolar lavage was performed using 1.5 ml of phosphate buffer (pH 7.2) to collect bronchoalveolar lavage fluid. The number of leukocyte cells in the wash was measured using a hematology analyzer (Drew Scientific Inc., HEMAVET  HV950FS, M-950HV) were used to count leukocyte counts. The results are shown in Table 5 below in terms of percent inhibition of pulmonary bronchial inflammation based on the number of leukocyte cells in the negative control group (1% CMC [carboxymethyl cellulose] treated group).

Administration condition % Inhibition of pulmonary bronchial inflammation Example 1-1 17.8 Examples 1-2 22.5 Example 1-3 23.6 Examples 1-4 23.7 Examples 1-5 24.4 Examples 1-6 25.5 Examples 1-7 29.6 Examples 1-8 19.2 Examples 1-9 18.9 Comparative Example 1-1 8.7 Comparative Example 1-2 6.4 Comparative Example 1-3 6.5 Comparative Example 1-4 5.7 Comparative Example 1-5 5.8

As shown in Table 5, it was found that the extract of the present invention is superior in the effect of inhibiting leukocyte count in bronchoalveolar lavage fluid, and thus the extracts are excellent in inhibition of inflammation.

EXPERIMENTAL EXAMPLE 4. Confirmation of asthma treatment by taking an extract of herbal medicine mixture

Each of the extracts of Example 1 and Comparative Example 1 was administered to 20 to 50 patients diagnosed with asthma at both hospitals in Sep. 2012. Seven patients in each group received 110 ml of 3 times daily for 20 days, (5 points: excellent, 4 points: excellent, 3 points: normal, 2 points: poor, 1 point: very poor) in the following Table 6 after taking 20 days. Of the cough and sputum.

Condition Asthma improvement effect Example 1-1 3.7 Examples 1-2 3.9 Example 1-3 3.8 Examples 1-4 4.0 Examples 1-5 3.9 Examples 1-6 4.0 Examples 1-7 4.3 Examples 1-8 3.9 Examples 1-9 3.8 Comparative Example 1-1 2.2 Comparative Example 1-2 2.3 Comparative Example 1-3 2.2 Comparative Example 1-4 2.0 Comparative Example 1-5 1.4 Untreated group 1.0 5 points: improvement effect 80% or more, 4 points: improvement effect 60% or more, 3 points: improvement effect 40% or more
2 points: improvement effect 20% or more, 1 point: no improvement effect

Referring to Table 6, it was shown that the extract of the herbal medicine mixture of the present invention has excellent asthma treatment effect. In particular, it was confirmed that asthma treatment effect of Example 1-7 extract containing all of herbal medicines other than mackumundo, underwear, lily, gyeonggyeong and rice was the most excellent.

<Experimental Example 5> Toxicity test>

Experimental Example 5-1. Acute toxicity

The toxicity of the extracts (lyophilisates) of the herbal preparations of Examples 1-1 and 1-7 of the present invention to the animal body in an acute (within 24 hours) when an excessive amount of the extracts were taken in a short period of time and the mortality rate was determined This experiment was performed. Twenty mice of the general mouse ICR mouse line were assigned to each of the control and experimental groups. In the control group, only the PEG-400 / tween-80 / EtOH (8/1/1, v / v / v) -400 / tween-80 / EtOH (8/1/1, v / v / v). After 24 hours of administration, the mortality rate was examined. As a result, it was confirmed that all of the mice survived in the control group and in the test group administered with the herbal mixture extract of Examples 1-1 and 1-7 of the present invention at the concentration of 2 g / kg / day .

Experimental Example 5-2. Organ organs toxicity test in experimental group and control group

In the long-term toxicity test, the extracts (lyophilisates) of the herbal mixture of Examples 1-1 and 1-7 of the present invention were administered to C57BL / 6J mice (10 rats per group) for 8 weeks at each concentration. In order to investigate the effects on the organs (tissues) of animals, an experimental group to which extracts of herbal medicine mixtures of Examples 1-1 and 1-7 of the present invention were administered and PEG-400 / tween-80 / After 8 weeks from the control group, the blood concentration of glutamate-pyruvate transferase (GPT) and blood urea nitrogen (BUN) was measured by Select E (Vital Scientific NV, Netherland ) Instrument. As a result, GPT, which is known to be related to hepatotoxicity, and BUN, which is known to be related to renal toxicity, showed no significant difference compared to the control group. In addition, liver and kidney were cut from each animal, followed by a general tissue section preparation, histological observation with an optical microscope, and no abnormalities were observed in all tissues.

&Lt; Formulation Example 1 >

1-1. Manufacture of tablets

200g of the extract (lyophilized product) of the crude drug mixture of Examples 1-7 of the present invention was mixed with 175.9g of lactose, 180g of potato starch and 32g of colloidal silicic acid. To this mixture was added a 10% gelatin solution, which was pulverized and passed through a 14-mesh sieve. This was dried, and a mixture obtained by adding 160 g of potato starch, 50 g of talc and 5 g of magnesium stearate was made into tablets.

1-2. Injection preparation

1 g of the extract (lyophilized product) of the crude drug mixture of Examples 1-7 of the present invention, 0.6 g of sodium chloride and 0.1 g of ascorbic acid were dissolved in distilled water to make 100 ml. This solution was placed in a bottle and sterilized by heating at 20 DEG C for 30 minutes.

<Formulation Example 2: Food Preparation>

2-1. Manufacture of cooking seasonings

The lyophilized mixture extract (lyophilized product) of Example 1-7 of the present invention was added to the cooking seasoning at 1 wt% to prepare a cooking sauce for health promotion.

2-2. Manufacture of flour food products

(Lyophilized product) of the crude drug mixture of Examples 1-7 of the present invention was added to flour at 0.1% by weight, and bread, cake, cookies, crackers and noodles were prepared using this mixture to prepare health promotion foods Respectively.

2-3. Manufacture of soups and gravies

The health enhancing soup and the juice were prepared by adding the extract (lyophilized product) of the herbal mixture of Examples 1-7 of the present invention to the soup and juice at 0.1 wt%.

2-4. Manufacture of dairy products

The lyophilized product extract (lyophilized product) of Examples 1-7 of the present invention was added to milk in an amount of 0.1% by weight and various dairy products such as butter and ice cream were prepared using the milk.

2-5. Vegetable juice manufacturing

0.5 g of the herbal mixture extract (lyophilized product) of Example 1-7 of the present invention was added to 1,000 ml of tomato juice or carrot juice to prepare health promotion vegetable juice.

2-6. Manufacture of fruit juice

0.1 g of the herbal mixture extract (lyophilized product) of Example 1-7 of the present invention was added to 1,000 ml of apple juice or grape juice to prepare fruit juice for health promotion.

Claims (10)

Prevention or treatment of respiratory diseases selected from the group consisting of asthma, chronic obstructive pulmonary disease, bronchitis, sore throat, tonsillitis and laryngitis, characterized in that it contains an extract of a herbal medicine mixture comprising mungum dong, underwear, lily, / RTI &gt; The method according to claim 1,
Wherein the herbal medicine mixture comprises 50 to 200 parts by weight of an inner liner, 50 to 200 parts by weight of a lily, 10 to 100 parts by weight of a lily oil, and 10 to 50 parts by weight of rice, based on 100 parts by weight of marshmallow Bronchitis, sore throat, tonsillitis, and laryngitis. The composition for preventing or treating respiratory diseases according to claim 1, 3. The method according to claim 1 or 2,
Wherein said herbal mixture contains 50 to 200 parts by weight of chicken hair, 10 to 100 parts by weight of oyster, 50 to 200 parts by weight of supernatant, 10 to 100 parts by weight of coriander, 10 to 100 parts by weight of corn husk, 10 to 100 parts by weight of corn husk, Wherein at least one herbal medicine is selected from the group consisting of 100 to 100 parts by weight of ginger, 10 to 100 parts by weight of ginger, 10 to 100 parts by weight of jujube and 10 to 100 parts by weight of licorice. , Tonsillitis, and laryngitis. The composition for preventing or treating respiratory diseases according to claim 1, 3. The method according to claim 1 or 2,
Wherein the extract of the crude drug mixture is prepared by extracting a crude drug mixture comprising marshmallow, lighter, lily, Gyeonggi, and rice with water, a lower alcohol of C1 to C4 or a mixed solvent thereof. Diseases, bronchitis, sore throat, tonsillitis, and sore throat. Prevention or improvement of respiratory diseases selected from the group consisting of asthma, chronic obstructive pulmonary disease, bronchitis, sore throat, tonsillitis and laryngitis, characterized in that it contains an extract of a herbal medicine mixture comprising ginseng root, undergarment, lily, Health functional food for. 6. The method of claim 5,
The herbal medicine mixture contains 100 to 100 parts by weight of marshmallow, 50 to 200 parts by weight of herbaceous fungus, 50 to 200 parts by weight of lily, 10 to 100 parts by weight of ginseng and 10 to 50 parts by weight of rice, Asthma, chronic obstructive pulmonary disease, bronchitis, sore throat, tonsillitis and laryngitis. The method according to claim 5 or 6,
Wherein said herbal mixture contains 50 to 200 parts by weight of chicken hair, 10 to 100 parts by weight of oyster, 50 to 200 parts by weight of supernatant, 10 to 100 parts by weight of coriander, 10 to 100 parts by weight of corn husk, 10 to 100 parts by weight of corn husk, Wherein at least one herbal medicine is selected from the group consisting of 100 to 100 parts by weight of ginger, 10 to 100 parts by weight of ginger, 10 to 100 parts by weight of jujube and 10 to 100 parts by weight of licorice. , Tonsillitis, and sore throat. The present invention relates to a health functional food for preventing or ameliorating respiratory diseases. The method according to claim 5 or 6,
Wherein the extract of the crude drug mixture is prepared by extracting a crude drug mixture comprising marshmallow, lighter, lily, Gyeonggi, and rice with water, a lower alcohol of C1 to C4 or a mixed solvent thereof. Diseases, bronchitis, sore throat, tonsillitis, and sore throat. (1 step) preparing a herbal mixture by mixing 100 parts by weight of corn germ, 50-200 parts by weight of lingers, 50-200 parts by weight of lilies, 10-100 parts by weight of gill, and 10-50 parts by weight of rice.
(Step 2) Mixing the crude drug mixture of the above-mentioned one step with an extraction solvent having a total weight of 1 to 10 times the total weight of the crude drug mixture and extracting the mixture at 70 to 130 ° C for 1 to 10 hours; And
(Step 3) removing the solid content of the extract of the two steps and collecting the filtrate;
A method for producing an extract of a herbal medicine mixture, which comprises a ginseng root, an obturator, a lily, a ginseng, and rice. 10. The method of claim 9,
Wherein the extraction solvent of step 2 is selected from water, C1 to C4 lower alcohols or a mixed solvent thereof.

Images